Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-07-21 OYLER JOHN Chief Executive Officer Sale −11,900 $24.58 $292K 5,639,665
2021-07-21 OYLER JOHN Chief Executive Officer Sale −800 $304.93 $244K 14,460
2021-07-21 OYLER JOHN Chief Executive Officer Sale −500 $306.04 $153K 13,960
2021-07-21 OYLER JOHN Chief Executive Officer Sale −5,150 $307.04 $1.6M 8,810
2021-07-21 OYLER JOHN Chief Executive Officer Sale −3,193 $308.11 $984K 5,617
2021-07-21 OYLER JOHN Chief Executive Officer Sale −1,407 $309.01 $435K 4,210
2021-07-21 OYLER JOHN Chief Executive Officer Sale −1,200 $310.05 $372K 3,010
2021-07-21 OYLER JOHN Chief Executive Officer Sale −1,610 $311.20 $501K 1,400
2021-07-21 OYLER JOHN Chief Executive Officer Sale −1,100 $312.28 $344K 300
2021-07-21 OYLER JOHN Chief Executive Officer Sale −300 $313.36 $94K 0
2021-07-20 OYLER JOHN Chief Executive Officer Sale −27,700 $24.61 $682K 5,849,945
2021-07-20 OYLER JOHN Chief Executive Officer Sale −5,790 $316.85 $1.8M 10,205
2021-07-20 OYLER JOHN Chief Executive Officer Sale −2,300 $318.20 $732K 7,905
2021-07-20 OYLER JOHN Chief Executive Officer Sale −3,100 $318.88 $989K 4,805
2021-07-20 OYLER JOHN Chief Executive Officer Sale −1,900 $320.05 $608K 2,905
2021-07-20 OYLER JOHN Chief Executive Officer Sale −1,400 $321.18 $450K 1,505
2021-07-20 OYLER JOHN Chief Executive Officer Sale −1,505 $322.08 $485K 0
2021-07-15 Huang Jane CMO, Hematology Option exercise +6,914 $160.40 $1.1M 6,914
2021-07-15 Huang Jane CMO, Hematology Option exercise +8,831 $119.96 $1.1M 15,745
2021-07-15 Huang Jane CMO, Hematology Option exercise +5,255 $174.43 $917K 21,000

Page 64 of 99 · 1,972 trades